The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2016 | Dr Kostas Stamatopoulos on his research and patient empowerment work
Kostas Stamatopoulos, MD, PhD of The Centre for Research & Technology, Hellas, Greece discusses his work in chronic lymphocytic leukemia (CLL). Dr Stamatopoulos explains that he works on clinical, translational and basic research and in particular, identifying new approaches to risk stratification. Further, he is active in activities and initiatives around patient participation and empowerment.
Recorded at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA.
